Xilio Therapeutics Company
Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
Connections from
Last Funding Type:
Series C
Funding Status:
IPO
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
2016-01-01
Total Funding:
233000000
Employee Number:
11-50
Industry:
PharmTech